当前位置: 首页 > 详情页

Comparison of clinical features at the onset of Takayasu's arteritis according to age and sex.

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029. China. [2]Department of Emergency Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029. China.
出处:
ISSN:

摘要:
Takayasu's arteritis (TA) is a large-vessel vasculitis that predominantly affects the aorta, pulmonary artery and its main branches. The cause of TA is still unclear. To identify the clinical characteristics of TA at onset in different patient groups. The clinical manifestations, laboratory and angiographic findings of 53 patients with TA based on age at onset and sex were retrospectively analysed. The ratio of the incidence of TA in males and females was 1:4. Chest pain, reduced glomerular filtration rate (GFR), and multivessel involvement were the most common symptoms at TA onset in male patients. 17% of patients had an onset age >40 years, and the percentage of TA patients >40 years old with chest pain was significantly higher [6 (66.7%) vs 13 (29.5%) and p=0.031] than that in TA patients <40 years old. However, their renal artery involvement [1 (11.1%) vs 21 (47.7%)), p=0.042], abdominal aorta lesion [0 (0.0%) vs 16 (38.1%), p=0.030] and multiple vessel involvement [2 (22.2%) vs 32 (72.7%), p=0.004] were significantly less evident. Multivariate analysis showed that hypertension and thoracic aortic lesion were predisposing factors for TA diagnosis [odds ratio (OR)=3.918, 95% confidence interval (CI)=1.616-1566.185, p=0.026]. For patients with aortic insufficiency (OR=3.674, 95% CI=2.734-567.621, p=0.007) or aneurysm formation (OR=7.255, 95% CI=1.23-1628.614, p=0.044), ascending aortic lesion was an independent risk factor. Furthermore, patients >40 years with chest pain but no brachial pulse should be suspected to have TA. Hypertension and thoracic aortic lesion are predisposing factors for the diagnosis of TA. Male with TA was more prone to present with chest pain, multivessel involvement and reduced GFR. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版
大类 | 4 区 医学
小类 | 4 区 外周血管病 4 区 药学
最新[2023]版
大类 | 3 区 医学
小类 | 3 区 外周血管病 3 区 药学
JCR分区:
出版当年[2017]版:
Q3 PERIPHERAL VASCULAR DISEASE Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PERIPHERAL VASCULAR DISEASE Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院